Flamel Technologies (NASDAQ: FLML) announced the launch of Akovaz™, its formulation of ephedrine sulfate for injection, which received approval from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE